{"Retatrutide": [0], "(LY3437943)": [1], "is": [2], "an": [3], "agonist": [4], "of": [5, 30, 59, 64, 73, 172, 191, 292, 311, 318, 324, 334, 345], "the": [6, 28, 51, 57, 60, 142, 157, 207, 213, 218, 224, 231, 239, 245, 251, 257, 262, 268, 275, 283, 312, 356], "glucose-dependent": [7], "insulinotropic": [8], "polypeptide,": [9], "glucagon-like": [10], "peptide": [11], "1,": [12], "and": [13, 25, 168, 228, 272, 299, 308, 322, 332, 340, 343, 372, 395], "glucagon": [14], "receptors.": [15], "Its": [16], "dose-response": [17], "relationships": [18], "with": [19, 236, 280, 376, 399], "respect": [20], "to": [21, 75, 93, 150, 165, 368], "side": [22], "effects,": [23], "safety,": [24], "efficacy": [26], "for": [27, 134, 403], "treatment": [29, 402], "obesity": [31], "are": [32], "not": [33], "known.We": [34], "conducted": [35], "a": [36, 47, 71, 90, 169, 289, 377], "phase": [37], "2,": [38], "double-blind,": [39], "randomized,": [40], "placebo-controlled": [41], "trial": [42], "involving": [43], "adults": [44, 398], "who": [45, 69, 314, 326, 336, 347], "had": [46, 70, 303], "body-mass": [48], "index": [49], "(BMI,": [50], "weight": [52, 147, 162, 170, 202, 290], "in": [53, 62, 89, 145, 160, 200, 206, 212, 217, 223, 230, 238, 250, 256, 261, 267, 274, 282, 305, 355, 370, 388, 407, 410], "kilograms": [54], "divided": [55], "by": [56, 414], "square": [58], "height": [61], "meters)": [63], "30": [65, 78], "or": [66, 68, 123, 130, 174, 177, 179, 181, 294, 297, 301], "higher": [67], "BMI": [72], "27": [74], "less": [76], "than": [77], "plus": [79], "at": [80, 203, 392], "least": [81], "one": [82], "weight-related": [83], "condition.": [84], "Participants": [85], "were": [86, 193, 359, 363, 365, 373], "randomly": [87], "assigned": [88], "2:1:1:1:1:2:2": [91], "ratio": [92], "receive": [94], "subcutaneous": [95], "retatrutide": [96, 208, 252, 357, 401], "(1": [97], "mg,": [98], "4": [99, 105, 109, 121, 316, 384], "mg": [100, 106, 112, 118, 125, 317, 382], "[initial": [101, 107, 113, 119, 126], "dose,": [102, 108, 114, 120, 127], "2": [103, 115, 128], "mg],": [104, 110, 116, 122], "8": [111, 117, 328], "12": [124, 338], "mg])": [129], "placebo": [131, 240, 284], "once": [132], "weekly": [133], "48": [135, 166, 243, 287, 404], "weeks.": [136, 152], "The": [137, 195, 350], "primary": [138], "end": [139, 154], "point": [140], "was": [141, 184, 210, 254], "percentage": [143, 158, 198, 248], "change": [144, 159, 199, 249], "body": [146, 161, 201, 411], "from": [148, 163], "baseline": [149, 164], "24": [151, 204, 393], "Secondary": [153], "points": [155], "included": [156], "weeks": [167, 205, 394, 405], "reduction": [171, 291], "5%": [173, 293], "more,": [175, 178, 295, 298], "10%": [176, 296], "15%": [180, 300], "more.": [182], "Safety": [183], "also": [185], "assessed.We": [186], "enrolled": [187], "338": [188], "adults,": [189], "51.8%": [190], "whom": [192], "men.": [194], "least-squares": [196, 246], "mean": [197, 247], "groups": [209, 253, 358], "-7.2%": [211], "1-mg": [214, 258], "group,": [215, 221, 227, 233, 259, 265, 271, 277], "-12.9%": [216], "combined": [219, 225, 263, 269], "4-mg": [220, 264], "-17.3%": [222], "8-mg": [226, 270], "-17.5%": [229], "12-mg": [232, 276], "as": [234, 278], "compared": [235, 279], "-1.6%": [237], "group.": [241, 285], "At": [242, 286], "weeks,": [244, 288], "-8.7%": [255], "-17.1%": [260], "-22.8%": [266], "-24.2%": [273], "-2.1%": [281], "more": [302], "occurred": [304], "92%,": [306], "75%,": [307], "60%,": [309], "respectively,": [310], "participants": [313], "received": [315, 327, 337, 348], "retatrutide;": [319], "100%,": [320, 330], "91%,": [321], "75%": [323], "those": [325, 335, 346], "mg;": [329, 339], "93%,": [331], "83%": [333], "27%,": [341], "9%,": [342], "2%": [344], "placebo.": [349], "most": [351], "common": [352], "adverse": [353], "events": [354, 362], "gastrointestinal;": [360], "these": [361], "dose-related,": [364], "mostly": [366], "mild": [367], "moderate": [369], "severity,": [371], "partially": [374], "mitigated": [375], "lower": [378], "starting": [379], "dose": [380], "(2": [381], "vs.": [383], "mg).": [385], "Dose-dependent": [386], "increases": [387], "heart": [389], "rate": [390], "peaked": [391], "declined": [396], "thereafter.In": [397], "obesity,": [400], "resulted": [406], "substantial": [408], "reductions": [409], "weight.": [412], "(Funded": [413], "Eli": [415], "Lilly;": [416], "ClinicalTrials.gov": [417], "number,": [418], "NCT04881760.).": [419]}